RESUMO
TNBC is the most aggressive and hormone receptor-negative subtype of breast cancer with molecular heterogeneity in bulk tumors hindering effective treatment. Toll-like receptors (TLRs) have the potential to ignite diverse immune responses in the tumor microenvironment (TME). This encouraged us to screen their transcript expression in the publically available TCGA datasets. Reported molecular subtypes of TNBC may represent different TMEs and we observed differentially expressed TLRs (DETs) i.e. TLR3/4/6/8/9 have unique expression pattern in the TNBC subtypes, particularly in Immunomodulatory (IM) TNBC subtype. We then dissected expression of the DETs in immune and other components of the TME. TLR4 and TLR8 showed significant (p-value ≤ 0.05) negative partial correlation with tumor purity compared to other DETs. Interestingly, TLR4 and TLR8 expression showed a significant (adjusted p-value ≤ 0.05) correlation with different subsets of immune infiltrating cells having the highest correlation with monocytes/macrophage/dendritic cell populations mediating both innate and adaptive response in TNBC. The co-expression network identified genes correlated with these immune cells. Further, GSEA analysis of co-expressed genes showed a significant association of TLR8 partners with 'Peptide ligand binding', 'Gά-signaling', and 'Cytokine-cytokine interaction' while TLR4 associated genes correlated with 'Adaptive immune system' and 'Systemic lupus erythematosus' interactome. Finally, the expression of TLR4 protein was validated in a panel of TNBC cell lines. TLR4 expression in chemoresponsive TNBC was also validated in TNBC cell lines upon Paclitaxel (PTX) treatment. Collectively, the present study identified specific DETs in TNBC and discovered a prospective role of TLR4 and TLR8 in the maintenance of tumor-immune-microenvironment.
Assuntos
Regulação Neoplásica da Expressão Gênica , Linfócitos do Interstício Tumoral/imunologia , Receptor 4 Toll-Like/genética , Receptor 8 Toll-Like/genética , Neoplasias de Mama Triplo Negativas/genética , Microambiente Tumoral/genética , Antineoplásicos Fitogênicos/uso terapêutico , Linhagem Celular Tumoral , Biologia Computacional/métodos , Bases de Dados Factuais , Feminino , Perfilação da Expressão Gênica , Ontologia Genética , Redes Reguladoras de Genes , Humanos , Linfócitos do Interstício Tumoral/classificação , Linfócitos do Interstício Tumoral/patologia , Anotação de Sequência Molecular , Proteínas de Neoplasias/classificação , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/imunologia , Paclitaxel/uso terapêutico , Transdução de Sinais , Receptor 4 Toll-Like/imunologia , Receptor 8 Toll-Like/imunologia , Neoplasias de Mama Triplo Negativas/tratamento farmacológico , Neoplasias de Mama Triplo Negativas/imunologia , Neoplasias de Mama Triplo Negativas/mortalidade , Microambiente Tumoral/imunologiaRESUMO
A variety of Fc domain engineering approaches for abrogating the effector functions of mAbs exists. To address some of the limitations of the current Fc domain silencing approaches, we are exploring a less commonly considered option which relies on the deletion of the hinge. Removal of the hinge domain in humanized IgG1 and IgG4 mAbs obliterates their ability to bind to activating human Fc gamma receptors I and IIIA, while leaving their ability to engage their target antigen intact. Deletion of the hinge also reduces binding to the Fc neonatal receptor, although Fc engineering allows partial recovery of affinity. Engineering of the CH3 domain, stabilizes hinge deleted IgG4s and prevents Fab arm exchange. The faster clearing properties together with the pacified Fc make modality of the hinge deleted mAb an appealing solution for therapeutic and diagnostic applications.
RESUMO
Werner syndrome is a rare autosomal recessive disorder where Werner (WRN) gene is mutated. Being a nucleolar protein, during DNA damage, WRN translocates at the damage site where its catalytic function is required in DNA repair. Several studies have indicated that WRN acetylation may modulate WRN trafficking and catalytic function (Blander et al., 2002; Lozada et al., 2014). Among the six acetylation sites in WRN protein identified by mass-spectrometry analysis (Li et al., 2010) we here explore the role of acetylation sites in C-terminal of WRN (K1127, K1117, K1389, K1413) because the C- terminal domain is the hub for protein- protein interaction and DNA binding activity (Brosh et al. [4]; Muftuoglu et al., 2008; Huang et al., 2006). To explore their functional activity, we created mutations in these sites by changing the acetylation residue lysine (K) to a non-acetylation residue arginine (R) and expressed them in WRN mutant cell lines. We observed that K1127R and K1117R mutants are sensitive to the DNA damaging agents etoposide and mitomycin C and display deficient DNA repair. Importantly, deacetylation of WRN by SIRT1 (Mammalian Sir2) is necessary for restoration of WRN localization at nucleoli after completion of DNA repair. Among all putative acetylation sites, K1127R, K1117R and the double mutant K1127R/K1117R showed significantly delayed re-entry to the nucleolus after damage recovery, even when SIRT1 is overexpressed. These mutants showed partial interaction with SIRT1 compared to WT WRN. Thus, our results suggest that K1127 and K1117 are the major sites of acetylation, necessary for DNA repair. These results elucidate the mechanism by which SIRT1 regulates WRN trafficking via these acetylation sites during DNA damage.
Assuntos
Núcleo Celular/metabolismo , Reparo do DNA , Processamento de Proteína Pós-Traducional , Helicase da Síndrome de Werner/metabolismo , Acetilação , Transporte Ativo do Núcleo Celular , Sítios de Ligação , Linhagem Celular , Humanos , Lisina/genética , Mutação , Ligação Proteica , Sirtuína 1/metabolismo , Helicase da Síndrome de Werner/genéticaRESUMO
WRN protein, defective in Werner syndrome (WS), a human segmental progeria, is a target of serine/threonine kinases involved in sensing DNA damage. DNA-PK phosphorylates WRN in response to DNA double strand breaks (DSBs). However, the main phosphorylation sites and functional importance of the phosphorylation of WRN has remained unclear. Here, we identify Ser-440 and -467 in WRN as major phosphorylation sites mediated by DNA-PK.In vitro, DNA-PK fails to phosphorylate a GST-WRN fragment with S440A and/or S467A substitution. In addition, full length WRN with the mutation expressed in 293T cells was not phosphorylated in response to DSBs produced by bleomycin. Accumulation of the mutant WRN at the site of laser-induced DSBs occurred with the same kinetics as wild type WRN in live HeLa cells. While the wild type WRN relocalized to the nucleoli after 24 hours recovery from etoposide-induced DSBs, the mutant WRN remained mostly in the nucleoplasm. Consistent with this, WS cells expressing the mutants exhibited less DNA repair efficiency and more sensitivity to etoposide, compared to those expressing wild type. Our findings indicate that phosphorylation of Ser-440 and -467 in WRN are important for relocalization of WRN to nucleoli, and that it is required for efficient DSB repair.
Assuntos
Nucléolo Celular/enzimologia , Quebras de DNA de Cadeia Dupla , Proteína Quinase Ativada por DNA/metabolismo , Exodesoxirribonucleases/metabolismo , Proteínas Nucleares/metabolismo , RecQ Helicases/metabolismo , Bleomicina/farmacologia , Nucléolo Celular/efeitos dos fármacos , Reparo do DNA , Proteína Quinase Ativada por DNA/genética , Relação Dose-Resposta a Droga , Etoposídeo/farmacologia , Exodesoxirribonucleases/genética , Células HEK293 , Células HeLa , Humanos , Cinética , Mutação , Proteínas Nucleares/genética , Fosforilação , Processamento de Proteína Pós-Traducional , RecQ Helicases/genética , Serina , Transfecção , Helicase da Síndrome de WernerRESUMO
In the present study the ability of activated carbons developed from coconut shell fibers to remove alpha-picoline, beta-picoline, and gamma-picoline from aqueous solution in the broad range of concentrations (1-100 mg/L) is investigated. The derived carbons are designated as FAC (activated carbon derived from coconut shell fibers without any treatment) and ATFAC (activated carbon derived from acid treated coconut shell fibers). Systematic equilibrium and kinetic adsorption studies at different pH, temperatures, particle size, and solid-to-liquid ratio were carried out to determine various parameters necessary to establish the fixed bed reactors. The Langmuir and Freundlich models were applied and the data are not fitted well by the Freundlich and Langmuir equations, but the Langmuir model has an edge over Freundlich model. The monolayer adsorption capacity (Q0) as calculated using Langmuir adsorption isotherm of the activated carbons viz., FAC and ATFAC is found to increase with an increase in temperature confirming the endothermic process. The ATFAC has a higher sorption capacity than FAC. Overall the adsorption of alpha-picoline, beta-picoline, and y-picoline on FAC and ATFAC follow the order FACalpha-picoline < ATFACalpha-picoline < FAC gamma-picoline < ATFACbeta-picoline < FACbeta picoline < ATFAC gamma-picoline. The adsorption of alpha-,beta-, and gamma-picoline followed the pseudosecond-order rate kinetics. On the basis of these studies, various parameters such as effective diffusion coefficients, activation energy, and entropy of activation were evaluated to establish the mechanisms. It was concluded that the adsorption occurred through particle diffusion at low temperatures viz., 10 degrees C and 25 degrees C (except alpha-picoline where it was film diffusion), while at 40 degrees C it occurred through film diffusion. Similarly at concentrations of 25 and 50 mg/L the adsorption was particle diffusion controlled (except for alpha-picoline where it was film diffusion), while at > 50 mg/L it was film diffusion controlled.